SFV HEALTHCARE

Amgen Announces Quarterly Results, Exec Retirements

Amgen Inc. beat Wall Street estimates on second-quarter earnings and revenue.

Thousand Oaks Biotech Sells Drug Portfolio for Up to $562 Million

AliveGen Inc. in Thousand Oaks has sold its drug candidates to Biogen Inc. in a deal valued at up to $562 million.

Simulations Plus Subsidiary Gets NIH Grant

Dilisym Services Inc., a subsidiary of Simulations Plus Inc. in Lancaster, has been awarded a $1.7 million grant from the National Institutes of Health to build a software platform for modeling medication-induced kidney injury.

Avita Medical Builds Leadership Team

Avita Medical has appointed three new leaders to its management team at its Valencia headquarters.

Preview: Smart Heart Monitor

A paperclip-sized revolution in cardiac electrophysiology is afoot in a bright white lab at Abbott Laboratories in Sylmar, where the world’s first Bluetooth- and smartphone-enabled implantable cardiac monitor are coming off the assembly line.

Tease photo

Amgen Partners with Cedars-Sinai on Research

Amgen Inc. has entered into a three-year research partnership with Cedars-Sinai Medical Center in Los Angeles to assess health outcomes in patients with cancer, osteoporosis, cardiovascular disease and migraine.

MannKind Pays Down Debt With Shares

MannKind Corp. in Westlake Village has issued 7.3 million shares to creditor Deerfield to pay down $7 million in debt, according to Securities and Exchange documents filed Friday.

Cure Pharmaceutical Buys Therapix Assets

Cure Pharmaceutical in Oxnard announced Wednesday that it has signed a term agreement for the acquisition of the non-pain assets of Therapix Biosciences Ltd., a clinical-stage pharmaceutical company that is developing cannabinoid-based medications.

Simulations Plus Beats Wall St. on Revenue

Simulations Plus Inc. reported on Tuesday profits of $2.4 million for its third fiscal quarter.

L.A. County Selects Leadership for Bioscience Promotion Agency

Los Angeles County has appointed two executives to launch a new agency to promote the bioscience industry, officials announced July 5.

Tease photo

Preview: Conejo's Biotech Cluster

Atara Biotherapeutics opens ATOM center in Thousand Oaks.

Amgen Sues Competitor Over Sensipar Generic

Amgen Inc. in Thousand Oaks has filed a lawsuit against drugmaker Intas Pharmaceuticals Inc. and its subsidiary Accord Healthcare Inc. over its plans to manufacture a generic of Amgen’s medication Sensipar.

City Council Urges Kaiser to Keep NoHo Jobs

The Los Angeles. City Council has unanimously passed a resolution urging Kaiser Permanente not to cut 306 jobs in Los Angeles, including 34 positions at a laboratory in North Hollywood.

Valley-Region Companies Join Russell 3000

A pair of health-related companies in the Valley region announced they joined the Russell 3000 Index this week.

Antelope Valley Hospital to Lay Off 137 Workers

The Antelope Valley Hospital plans to lay off 137 workers, according to a notice filed June 18 with the state Employee Development Department.

Tease photo